Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Clinical trial NCT02364076 · UNKNOWN
Trial details
- NCT number
- NCT02364076
- Sponsor
- Georgetown University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2019-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.